2BB score and signals
Summit Therapeutics Inc.’s current 2BB score is 55 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 74 | High |
| Momentum | 39 | Weakening |
| Financial strength | 41 | Normal |
| Risk | 22 | Low (provisional) |
2BBBullish & Bearish
Summit Therapeutics Inc. (SMMT) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 55 out of 100.
Summit Therapeutics Inc.’s current 2BB score is 55 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 74 | High |
| Momentum | 39 | Weakening |
| Financial strength | 41 | Normal |
| Risk | 22 | Low (provisional) |
| Founded | Aug 4, 2004 |
| Employees | 61 |
| 52-week range | $12.07 – $29.23 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-04-28 | — | -0.3089 | — | $9.39M |
| 2027-02-22 | — | -0.3933 | — | $3.78M |
| 2026-11-11 | — | -0.2863 | — | $68,003.00 |
| 2026-07-23 | — | -0.2849 | — | $0.00 |